Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Periodontal care in general practice: 20 important FAQs - Part two

A Correction to this article was published on 24 January 2020

This article has been updated


This is the second in a two-part series that aims to summarise answers to common questions facing dentists in general practice. The first part of this series is entitled 'Periodontal care in general practice: 20 important FAQs − Part one' (Br Dent J 2019;226: 850-854) and contains the first set of ten FAQs.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Change history

  • 24 January 2020

    Author's correction note: When this article was initially published, the following boxes in Table 1 were incorrect: In the top row of the Dosage column, 'Doxycyline 200 mg (loading dose), 100 mg OD for 14 days' should have read 'Doxycyline 200 mg (loading dose), 100 mg OD for 21 days' In the top r...


  1. 1.

    Murakami S, Mealey B L, Mariotti A, Chapple I L C. Dental plaque-induced gingival conditions. J Clin Periodontol 2018; 45 (Suppl 20): S17-S27.

  2. 2.

    Tipton D A, Stricklin G P, Dabbous M K. Fibroblast heterogeneity of collagenolytic response to cyclosporine. J Cell Biochem 1991; 46: 152-165.

  3. 3.

    Hallmon W W, Rossman J A. The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts. Periodontol 2000 1999; 21: 176-196.

  4. 4.

    Nishikawa S, Taha H, Hamasaki A et al. Nifedipine-induced gingival hyperplasia: a clinical and in vitro study. J Periodontol 1991; 62: 30-35.

  5. 5.

    Heasman P A, Hughes F J. Drugs, medications and periodontal disease. Br Dent J 2014; 217: 411-419.

  6. 6.

    Butterworth C J, Chapple I L C. Drug-induced gingival overgrowth: a case of auto-correction of incisor drifting. Dent Update 2001; 28: 411-416.

  7. 7.

    Ilgenli T, Atilla G, Baylas H. Effectiveness of peri-odontal therapy in patients with drug-induced gingival overgrowth. Long-term results. J Periodontol 1999; 70: 967-972.

  8. 8.

    Jepsen S, Caton J G, Albandar J M et al. Periodontal manifestations of systemic diseases and developmental and acquired conditions: consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol 2018; 45(S20): S219-S229.

  9. 9.

    Hughes F J. Clinical problem solving in periodontology and implantology. 1st ed. Churchill Livingstone Elsevier, 2013.

  10. 10.

    Magnusson I, Lindhe J, Yoneyama T, Liljenberg B. Recolonization of a subgingival microbiota following scaling in deep pockets. J Clin Periodontol 1984; 11: 193-207.

  11. 11.

    Timmerman M F, van der Weijden G A, van Steenbergen T J, Mantel M S, de Graaff J, van der Velden U. Evaluation of the long-term efficacy and safety of locally-applied minocycline in adult periodontitis patients. J Clin Periodontol 1996; 23: 707-716.

  12. 12.

    Garrett S, Adams DF, Bogle G et al. The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 months. J Periodontol 2000; 71: 22-30.

  13. 13.

    Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002; 29(S3): 136-159.

  14. 14.

    Haffajee A D, Socransky S S, Gunsolley J C. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003; 8: 115-181.

  15. 15.

    Pjetursson B E, Helbling C, Weber H P et al. Peri-implantitis susceptibility as it relates to periodontal therapy and supportive care. Clin Oral Implants Res 2012; 23: 888-894.

  16. 16.

    Sgolastra F, Petrucci A, Severino M, Gatto R, Monaco A. Periodontitis, implant loss and peri-implantitis. A meta-analysis. Clin Oral Implants Res 2015; 26: e8-e16.

  17. 17.

    Koldsland O C, Scheie A A, Aass A M. Prevalence of implant loss and the influence of associated factors. J Periodontol 2009; 80: 1069-1075.

  18. 18.

    Matarasso S, Rasperini G, Iorio Siciliano V, Salvi G E, Lang NP, Aglietta M. A 10-year retrospective analysis of radiographic bone-level changes of implants supporting single-unit crowns in periodontally compromised vs. periodontally healthy patients. Clin Oral Implants Res 2010; 21: 898-903.

  19. 19.

    Linkevicius T, Vindasiute E, Puisys A, Linkeviciene L, Maslova N, Puriene A. The influence of the cementation margin position on the amount of undetected cement. A prospective clinical study. Clin Oral Implants Res 2013; 24: 71-76.

  20. 20.

    Roccuzzo M, Bonino L, Dalmasso P, Aglietta M. Long-term results of a three arms prospective cohort study on implants in periodontally compromised patients: 10-year data around sandblasted and acid-etched (SLA) surface. Clin Oral Implants Res 2014; 25: 1105-1112.

  21. 21.

    Levin L, Halperin-Sternfeld M. Tooth preservation or implant placement: a systematic review of long-term tooth and implant survival rates. J Am Dent Assoc 2013; 144: 1119-1133.

  22. 22.

    Schwendicke F, Stolpe M, Müller F. Professional oral health care for preventing nursing home-acquired pneumonia: A cost-effectiveness and value of information analysis. J Clin Periodontol 2017; 44: 1236-1244.

  23. 23.

    Chapple L, Chapple I. Risk assessment in periodontal disease. Dent Update 2018; 45: 920-926.

  24. 24.

    Genco R J, Borgnakke W. Risk factors for periodontal disease. Periodontol 2000 2013; 62: 59-94.

  25. 25.

    Lang N P, Tonetti M S. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health Prev Dent 2003; 1: 7-16.

  26. 26.

    Page R C, Martin J, Krall E A, Mancl L, Garcia R. Longitudinal validation of a risk calculator for periodontal disease. J Clin Periodontol 2003; 30: 819-827.

  27. 27.

    Matuliene G, Studer R, Lang N P et al. Significance of periodontal risk assessment in the recurrence of periodontitis and tooth loss. J Clin Periodontol 2010; 37: 191-199.

  28. 28.

    Asimakopoulou K, Newton J T, Daly B, Kutzer Y, Ide M. The effects of providing periodontal disease risk information on psychological outcomes - a randomized controlled trial. J Clin Periodontol 2015; 42: 350-355.

  29. 29.

    Sharma P, Busby M, Chapple L, Matthews R, Chapple I. The relationship between general health and lifestyle factors and oral health outcomes. Br Dent J 2016; 221: 65-69.

  30. 30.

    Asimakopoulou K, Nolan M, McCarthy C, Newton J T. The effect of risk communication on periodontal treatment outcomes: A randomised controlled trial. J Periodontol 2019; 90: 948-956.

  31. 31.

    Axelsson P, Lindhe J. The significance of maintenance care in the treatment of periodontal disease. J Clin Periodontol 1981; 8: 281-294.

  32. 32.

    Ramfjord S P, Morrison E C, Burgett F G et al. Oral hygiene and maintenance of periodontal support. J Periodontol 1982; 53: 26-30.

  33. 33.

    Axelsson P, Nyström B, Lindhe J. The long-term effect of a plaque control programme on tooth mortality, caries and periodontal disease in adults. Results after 30 years of maintenance. J Clin Periodontol 2004; 31: 749-757.

  34. 34.

    Nyman S, Lindhe J. A longitudinal study of combined periodontal and prosthetic treatment of patients with advanced periodontal disease. J Periodontol 1979; 50: 163-169.

  35. 35.

    Rosling B, Serino G, Hellström M K, Socransky S S, Lindhe J. Longitudinal periodontal tissue alterations during supportive therapy. J Clin Periodontol 2001; 28: 241-249.

  36. 36.

    Ramseier C A, Nydegger M, Walter C et al. Time between recall visits and residual probing depths predict long-term stability in patients enrolled in supportive periodontal therapy. J Clin Periodontol 2019; 46: 218-230.

  37. 37.

    British Society of Periodontology. Referral policy and parameters of care. Available online at (accessed 4 April 2019).

Download references

Author information



Corresponding author

Correspondence to Reena Wadia.

Ethics declarations

Prof Chapple acts as an adviser to Oral Health Innovations, who license PreViser software in the UK and Ireland

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wadia, R., Chapple, I. Periodontal care in general practice: 20 important FAQs - Part two. Br Dent J 227, 875–880 (2019).

Download citation


Quick links